Stock Events

Stock Events

Diffusion Pharmaceuticals 

$4.4
43
-$1.51-25.55% Wednesday 20:00

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
8.97M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

13NovExpected
Q1 2022
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-2.22
-1.83
-1.43
-1.04
Expected EPS
-1.95
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-15.59MNet Income

Analyst Ratings

$22.00Average Price Target
The highest estimate is 31.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DFFN. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a major player in the medical devices sector, directly competing with CervoMed in multiple healthcare technology markets.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes with CervoMed in developing advanced medical devices for various therapeutic areas.
Stryker
SYK
Mkt Cap136.19B
Stryker operates in the same sectors as CervoMed, particularly in orthopedics and neurotechnology, making them direct competitors.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a broad range of medical devices and diagnostics, overlapping with CervoMed's product lines.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical provides robotic-assisted surgical systems, competing with CervoMed's innovations in medical technology.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet competes in the musculoskeletal healthcare sector, directly challenging CervoMed's offerings in orthopedic devices.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valve therapy and critical care, areas where CervoMed also operates.
Baxter International
BAX
Mkt Cap9.49B
Baxter International competes with CervoMed in the development and manufacturing of medical products, including hospital and renal care devices.
Resmed
RMD
Mkt Cap36.04B
ResMed is known for its sleep and respiratory care devices, competing with CervoMed's products in similar therapeutic areas.

About

Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
Show more...
CEO
Employees
16
Country
US
ISIN
US2537482067
WKN
000A3DKFH

Listings

F
DE
DP8.F
XNAS
US
CRVO
BOATS
BOATS
CRVO.BOATS

0 Comments

Share your thoughts

FAQ

What is Diffusion Pharmaceuticals stock price today?▼
The current price of DFFN is $4.4 USD — it has decreased by -25.55% in the past 24 hours. Watch Diffusion Pharmaceuticals stock price performance more closely on the chart.
What is Diffusion Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Diffusion Pharmaceuticals stocks are traded under the ticker DFFN.
What is Diffusion Pharmaceuticals market cap?▼
Today Diffusion Pharmaceuticals has the market capitalization of 8.97M
What is Diffusion Pharmaceuticals revenue for the last year?▼
Diffusion Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Diffusion Pharmaceuticals net income for the last year?▼
DFFN net income for the last year is -15.59M USD.
How many employees does Diffusion Pharmaceuticals have?▼
As of April 02, 2026, the company has 16 employees.
In which sector is Diffusion Pharmaceuticals located?▼
Diffusion Pharmaceuticals operates in the Manufacturing sector.
When did Diffusion Pharmaceuticals complete a stock split?▼
The last stock split for Diffusion Pharmaceuticals was on August 17, 2023 with a ratio of 1:1.5.
Where is Diffusion Pharmaceuticals headquartered?▼
Diffusion Pharmaceuticals is headquartered in Charlottesville, US.